Inactive Instrument

Highlights Aastrom Biosciences Inc Nasdaq

Equities

US00253U3059

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 19	Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing	MT
Mar. 15	Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vericel Q4 EPS, Revenue Increase; Issues 2024 Outlook -- Shares Rise Pre-Bell	Feb. 29	MT
Vericel Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Vericel Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Vericel Corporation Provides Earnings Guidance for the Fiscal Year 2024	Feb. 29	CI
Earnings Flash (VCEL) VERICEL CORPORATION Reports Q4 Revenue $65M, vs. Street Est of $64M	Feb. 29	MT
North American Morning Briefing : Fed's Preferred -2-	Feb. 29	DJ
North American Morning Briefing : Intel Drags Down -2-	Jan. 26	DJ
Vericel Corporation Provides Earnings Guidance for the Year 2024	Jan. 10	CI
Vericel Reports Q4 Preliminary Unaudited Revenue; Shares Rise	Jan. 09	MT
Vericel Corporation Provides Earnings Guidance for the Fourth Quarter and Full-Year 2023	Jan. 09	CI
Vericel Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Earnings Flash (VCEL) VERICEL CORPORATION Posts Q3 Revenue $45.6M, vs. Street Est of $45.2M	Nov. 08	MT
Vericel Corporation Provides Total Net Revenue Guidance for 2023	Nov. 08	CI
Vericel Corporation Announces U.S. Commercial Availability of NexoBrid (Anacaulase-Bbb) for the Treatment of Severe Thermal Burns in Adults	23-09-20	CI
Vericel Seeks Acquisitions	23-09-12	CI
Earnings Flash (VCEL) VERICEL CORPORATION Posts Q2 Revenue $45.9M, vs. Street Est of $42.1M	23-08-02	MT
Vericel Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-02	CI
Vericel Corporation Revises Earnings Guidance for the Year 2023	23-08-02	CI
Vericel Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Vericel Corporation Raises Revenue Guidance for the Fiscal Year 2023	23-05-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aastrom Biosciences Inc Nasdaq

Equities

US00253U3059

Highlights

Filters